Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma

Cancer Immunology, Immunotherapy

Volumn 50, Issue 9, 2001, Pages 491-501

  Hegardt, P ^a   Widegren, B ^a   Li, L ^a   Sjogren B ^a   Kjellman, C ^a   Sur, I ^a   Sjogren H O ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Colon carcinoma; IL 18; Immunosuppression; Nitric oxide; Tumor bearer

Indexed keywords

CD3 ANTIGEN; ENTEROTOXIN; GAMMA INTERFERON; INTERLEUKIN 18; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE;

ADENOCARCINOMA; ANIMALS; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOKINES; DENDRITIC CELLS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; FEMALE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-18; MACROPHAGES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED BN; RATS, WISTAR; RNA; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0035175668     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620100230     Document Type: Article

References (48)

1. Immunomodulation of cancer: Potential use of selectively replicating agents
2. Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine
3. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway
4. Nitric oxide suppresses human T lymphocyte proliferation through IFN- gamma-dependent and IFN-gamma-independent induction of apoptosis
5. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
6. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells
7. Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma
8. Zinc finger transcription factors as molecular targets for nitric oxide- mediated immunosuppression: Inhibition of IL-2 gene expression in murine lymphocytes
9. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
10. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death
11. Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
14. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice
15. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression
16. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo
17. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients
18. 15N]nitrate in biological fluids
19. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria
20. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
21. Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas
22. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin
23. Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: Inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect
24. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
25. Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer
26. Nitric oxide involvement in tumor-induced immunosuppression
27. Nitric oxide and macrophage function
28. Construction and use of a safe and efficient amphotropic packaging cell line
29. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
30. Interleukin 10 pretreatment protects target cells from tumor- and allospecific cytotoxic T cells and downregulates HLA class I expression
31. Augmentation of an antitumor CTL response in vivo by inhibition of suppressor macrophage nitric oxide
32. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
33. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
34. T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma
35. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
36. Effects of nitric oxide on the induction and differentiation of Th1 cells
37. Cloning of a new cytokine that induces IFN-gamma production by T cells
38. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T- cell responses
39. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
40. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount antitumour responses to PPD-coupled tumour cells
41. + rat glioma
42. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector
43. Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production
44. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice
45. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells
46. Altered immune responses in mice lacking inducible nitric oxide synthase
47. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
48. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoforrmans through production of gamma interferon by natural killer cells